Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cerebrospinal Fluid
100%
Etiological Factors
100%
Amyotrophic Lateral Sclerosis
100%
Peptide Biomarkers
100%
Motor Activity
33%
Neurodegeneration
22%
Mechanism of Action
22%
Etiology
22%
BV2 Microglia
22%
Rotarod Test
22%
Neuroprotective Peptide
22%
Neuronal Damage
11%
Mouse Model
11%
Microglia
11%
Pharmacodynamics
11%
Neuronal Cells
11%
Cellular Mechanisms
11%
Central Nervous System
11%
Neuroinflammation
11%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
11%
Cell Culture
11%
Molecular Mechanism
11%
Apoptotic Effect
11%
Inflammatory Response
11%
Specific Peptide
11%
Effective Treatment
11%
Nitric Oxide Synthase Activity
11%
Intranasal Administration
11%
Transthyretin
11%
Potential Biomarkers
11%
Cerebrospinal Fluid Samples
11%
Osteopontin
11%
Lower Motor Neuron
11%
Progressive Neurodegeneration
11%
Disease Etiology
11%
Co-activation
11%
C-terminal Fragments
11%
Direct Cytotoxicity
11%
Upper Motor Neuron
11%
Inflammation Model
11%
Quantitative Comparative Analysis
11%
Discovery-based
11%
Induced Inflammation
11%
Lipopolysaccharide-induced Inflammation
11%
Neuroscience
Amyotrophic Lateral Sclerosis
100%
Peptide
100%
Biological Marker
100%
Microglia
33%
Neurodegeneration
22%
Liquid Chromatography-Mass Spectrometry
22%
C-Terminus
11%
Neurodegenerative Disorder
11%
Cell Culture
11%
Cytotoxicity
11%
Osteopontin
11%
Central Nervous System
11%
Lipopolysaccharide
11%
Nitric Oxide Synthase
11%
Lower Motor Neuron
11%
Upper Motor Neuron
11%
Transthyretin
11%
Etiology of Amyotrophic Lateral Sclerosis
11%